Head-to-head · Cost-Efficiency Index
Fresh Day Meds vs Edessa
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Fresh Day Meds
Shoppers comfortable prepaying a 3-month quarterly bundle for the lowest per-month rate.
Visit Fresh Day MedsEdessa
A six-month committer, or someone willing to click past the front page to the table with the real monthly rate.
Visit EdessaThe verdict
Fresh Day Meds and Edessa tie on the Cost-Efficiency Index at 70/100, so neither wins outright on the numbers. For most shoppers we'd start with Fresh Day Meds (ranked #87, a hair above #91) — Shoppers comfortable prepaying a 3-month quarterly bundle for the lowest per-month rate. But Edessa is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Fresh Day Meds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Fresh Day Meds | Edessa |
|---|---|---|
| Cost-Efficiency Index | 70/100 | 70/100 |
| Semaglutide / mo | $140/mo (compounded) | $179/mo month-to-month for the injection; $160 on three months and $135 on six |
| Tirzepatide / mo | $179/mo (compounded) | $239/mo month-to-month; $219 on three months and $209 on six |
| Semaglutide / yr (modeled) | $1,680 | $2,148 |
| Tirzepatide / yr (modeled) | $2,148 | $2,868 |
| Coverage | All 50 states | Not disclosed |
| Oral / sublingual | No | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #87 | #91 |
Fresh Day Meds
70/100Where the value is
- No membership fees and free expedited shipping stated on-site
- LegitScript seal displayed
- Transparent quarterly-renewal totals shown next to the monthly-equivalent price, so the prepay isn't hidden
The tradeoffs
- The 'from $99/mo' headline is a new-patient-only, low-dose, 3-month-prepay price ($299 upfront) — the flat month-to-month rate is $140/mo
- No named compounding pharmacy or medical director/prescriber disclosed
Edessa
70/100Where the value is
- Each product page carries a plain three-rung table, so the commitment behind every figure is visible
- "Same price, every dose" is printed on each product page
- Names its operating entity and a full street address in Las Vegas, Nevada
The tradeoffs
- The front page leads with "Start for just $135", a six-month prepay on the semaglutide injection
- All three front-page cards quote the six-month rung, so the real monthly rates appear only after a click
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.